2023 Mammalian DNA Repair GRC & GRS
2023 Mammalian DNA Repair GRC & GRS
批准号:
10607587
负责人:
Patricia L Opresko
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-02-02 至 2024-01-31
关键词:
AddressAgeAgingAldehydesAlkylationAtmosphereCRISPR/Cas technologyCaliforniaCell physiologyCellsChemicalsClinicalClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCommunitiesDNADNA DamageDNA RepairDNA Repair PathwayDNA biosynthesisDefectDegenerative DisorderDevelopmentDiseaseEatingEnvironmental ExposureExposure toFacultyFemaleFosteringFunctional disorderGenderGenetic TranscriptionGenomeGenome StabilityGenome engineeringGenomic InstabilityHealthHumanHuman GenomeImmune signalingImmunotherapyIndustryInterventionKnowledgeLeadershipLearningLesionMaintenanceMalignant NeoplasmsMediatingMetabolismMethodsMitosisModelingModificationNeurodegenerative DisordersNormal CellOralOxygenParticipantPathway interactionsPostdoctoral FellowPremature aging syndromeRadiationResearchResearch PersonnelScienceScientistSeriesSourceSunlightTimeWomancareer developmentcombustion productexperiencefrontiergraduate studenthuman diseaseinhibitorinnovationinterestmeetingsmemberpostersprogramsrepairedresponsescientific atmospheresocialsymposiumtargeted treatmenttumor
中文摘要
项目摘要/摘要
这次为期5天的GRC和为期2天的GRS会议的重点是基因组不稳定性及其
对人类疾病和治疗的影响。暴露环境和内源性DNA来源
每个细胞的损伤每年会产生数千到100多万个损伤和对基因组的化学修饰
天。DNA损伤的常见环境来源包括阳光、辐射、醛和燃烧
副产物,而内源来源包括氧代谢、代谢物、烷基化和调节失调
DNA复制、转录和有丝分裂。在正常细胞中,大量的DNA修复和DNA损伤
反应机制成功地维持了基因组的稳定性。然而,这些中的缺陷
机制可导致一系列疾病,从罕见的发育和早衰综合征到
常见的癌症。这一哺乳动物DNA修复戈登研究会议(GRC)和相关的戈登
研究研讨会(GRS)将汇集不同的研究人员,研究保护
抗DNA损伤的基因组,以及当这些途径失效时对人类健康的后果。
此外,本次会议还将促进关于如何抑制DNA损伤反应和修复的讨论
机制,或利用这些机制中的功能障碍,来选择性地靶向肿瘤更有效
毒性更小的方式。目标是:1)让所有级别的研究人员(教职员工、来自
行业、博士后研究员和研究生)在这一快速发展中走向新的前沿和创新的方法
不断进步的研究领域。2)为青年科学家提供建立网络和练习演示的机会
他们的研究。3)创造包容和严谨的氛围,鼓励科学交流
可能促进合作或刺激新创新的想法。4)提供正式和非正式的职业生涯
发展机遇。我们将通过召集不同的演讲者和海报来实现这些目标
主讲人。GRC中44%的受邀演讲者是女性,我们预计GRC中约50%的演讲者是女性
演讲者为女性实习生。与关于类似主题的会议相比,这一GRC/GRS值得注意
提交的未发表的研究,以及会议期间广泛的非正式讨论时间,
用餐和空闲时间。
英文摘要
Project Abstract/Summary
This 5-day GRC and 2-day GRS conference is focused on the research of genomic instability and its
implications in human diseases and therapies. Exposures environmental and endogenous source of DNA
damage produce thousands to over a million lesions and chemical modifications to the genome per cell every
day. Common environmental sources of DNA damage include sunlight, radiation, aldehydes, and combustion
byproducts, while endogenous sources include oxygen metabolism, metabolites, alkylation and dysregulation
of DNA replication, transcription and mitosis. In normal cells, a multitude of DNA repair and DNA damage
response mechanisms successfully operate to maintain genomic stability. However, defects in these
mechanisms can result in diseases ranging from rare developmental and premature aging syndromes to
common cancers. This Mammalian DNA Repair Gordon Research Conference (GRC) and associated Gordon
Research Seminar (GRS) will bring together diverse researchers studying the mechanisms that protect the
genome against DNA damage, and the consequences for human health when these pathways fail.
Additionally, this conference will promote discussions on how to inhibit DNA damage response and repair
mechanisms, or leverage dysfunction in these mechanisms, to selectively target tumors in a more efficacious
and less toxic manner. The objectives are: 1) To expose researchers at all levels (faculty, researchers from
industry, postdoctoral fellows, and graduate students) to new frontiers and innovative methods in this rapidly
progressing research field. 2) To provide opportunities for young scientists to network and practice presenting
their research. 3) To generate an atmosphere of inclusion and rigor that encourages the exchange of scientific
ideas that may foster collaborations or spur new innovation. 4) To provide formal and informal career
development opportunities. We will achieve these objectives by assembling diverse speakers and poster
presenters. 44% of the invited speakers in the GRC are women and we expect approximately 50% of the GRS
speakers be female trainees. This GRC/GRS is notable compared to meetings on similar topics for the amount
of unpublished research that is presented, as well as the extensive informal discussion time during sessions,
meals, and free time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Excision Repair of Environmental Telomere Damage
-
批准号:10617802
-
项目类别:
-
资助金额:$93.13万
-
财政年份:2019
-
负责人:Patricia L Opresko
-
依托单位:
Excision Repair of Environmental Telomere Damage
-
批准号:10152593
-
项目类别:
-
资助金额:$91.26万
-
财政年份:2019
-
负责人:Patricia L Opresko
-
依托单位:
Excision Repair of Environmental Telomere Damage
-
批准号:10397054
-
项目类别:
-
资助金额:$91.26万
-
财政年份:2019
-
负责人:Patricia L Opresko
-
依托单位:
ROS driven mitochondrial-telomere dysfunction during environmental stress
-
批准号:8926521
-
项目类别:
-
资助金额:$20.79万
-
财政年份:2015
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomere Resistance to DNA Lesion Removal
-
批准号:8556629
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2013
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomere Resistance to DNA Lesion Removal
-
批准号:8854084
-
项目类别:
-
资助金额:$32.12万
-
财政年份:2013
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomere Resistance to DNA Lesion Removal
-
批准号:9064774
-
项目类别:
-
资助金额:$32.12万
-
财政年份:2013
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomere Resistance to DNA Lesion Removal
-
批准号:9277466
-
项目类别:
-
资助金额:$32.12万
-
财政年份:2013
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomere Resistance to DNA Lesion Removal
-
批准号:8728857
-
项目类别:
-
资助金额:$31.79万
-
财政年份:2013
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomeric DNA Loss and Repair
-
批准号:7900269
-
项目类别:
-
资助金额:$21.83万
-
财政年份:2009
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomeric DNA Loss and Repair
-
批准号:7893145
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2006
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomeric DNA Loss and Repair
-
批准号:7666812
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2006
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomeric DNA Loss and Repair
-
批准号:7283037
-
项目类别:
-
资助金额:$50.84万
-
财政年份:2006
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomeric DNA Loss and Repair
-
批准号:7475179
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2006
-
负责人:Patricia L Opresko
-
依托单位:
Mechanisms of Telomeric DNA Loss and Repair
-
批准号:7163208
-
项目类别:
-
资助金额:$48.25万
-
财政年份:2006
-
负责人:Patricia L Opresko
-
依托单位:
Genome Stability Program
-
批准号:10674835
-
项目类别:
-
资助金额:$4.02万
-
财政年份:1997
-
负责人:Patricia L Opresko
-
依托单位:
Genome Stability Program
-
批准号:10254107
-
项目类别:
-
资助金额:$3.57万
-
财政年份:1997
-
负责人:Patricia L Opresko
-
依托单位:
Genome Stability Program
-
批准号:10474521
-
项目类别:
-
资助金额:$4.02万
-
财政年份:1997
-
负责人:Patricia L Opresko
-
依托单位:
Genome Stability Program
-
批准号:10024347
-
项目类别:
-
资助金额:$3.95万
-
财政年份:1997
-
负责人:Patricia L Opresko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: